• Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List... 1/2/2025
• Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area 12/23/2024
• Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY 12/20/2024
• Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau 12/16/2024
• Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biophar... 12/13/2024
• Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinic... 12/6/2024
• Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong 12/4/2024